GlassScriptPhysician profile
Shelby Herr
NPI 1649975483
$1,799.10
in general payments reported to CMS, 2019-2025
7 companies · $961 in 2025
The $961 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $477 · 2024: $362 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $830.30 | 2023-2025 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $387.03 | 2024-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Ucb, INC. | $189.09 | 2023-2025 | Briviact |
| Biogen, INC. | $121.85 | 2025 | Vumerity |
| Amgen INC. | $120.61 | 2025 | Uplizna |
| Tg Therapeutics, INC. | $120.13 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $30.09 | 2025 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelby Herr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.